First publication of clinical efficacy data for PP353, in development for chronic Low Back PainTrial demonstrated that PP353 delivers clinically ...

24-month interim results from the first long-term study of SCS with automatic, objective, daily remote monitoring presented at NANS 2025 Annual Meeting This system integrates RESONANCE™ multiphase ...

Clinical trial of LX9211, an investigational non-opioid investigational therapy, demonstrated clinically significant benefits for people with diabetic peripheral neuropathic pain (DPNP) Investigators ...

Detailed price information for Autonomix Medical Inc (AMIX-Q) from The Globe and Mail including charting and trades.

Abbott Park, Illinois Tuesday, January 27, 2026, 13:00 Hrs [IST] ...

(RTTNews) - Silo Pharma, Inc. (SILO) on Tuesday announced positive early findings from its ongoing study evaluating the pharmacokinetics, safety, and tolerability of SP-26, a novel ketamine-based ...

Transvascular energy ablation showed a 79% response rate in reducing pancreatic cancer pain without opioids. Patients experienced a mean pain reduction of 4.96 points, equating to a 66% improvement in ...

At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.